Skip to content
Toggle navigation
News
Press Releases
In the News
Contact
About
Company Overview
Leadership
Board of Directors
Scientific Advisory Board
Investors
Tailwind
Platform
NK cells
Publications & Presentations
Pipeline & Programs
Join us
Leading Together
Find your Position
About
Company Overview
Leadership
Board of Directors
Investors
Tailwind
Platform
NK cells
Publications & Presentations
Pipeline & Programs
Join us
Leading Together
Find your Position
News
Press Releases
Contact
Terms of Use
Privacy Policy
Publications & Presentations
Back to Publications & Presentations
CAT-179, an allogeneic NK cell product expressing HER2-CAR, IL-15 and TGFβ dominant negative receptor, durably regresses HER2-expressing xenograft tumors in mic
AACR 2023 Annual Meeting Poster Presentation
Read More